相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Safety and Outcomes of Amikacin Liposome Inhalation Suspension for Mycobacterium abscessus Pulmonary Disease A NTM-NET study
Sanne Maria Henriette Zweijpfenning et al.
CHEST (2022)
Consensus management recommendations for less common non-tuberculous mycobacterial pulmonary diseases
Christoph Lange et al.
LANCET INFECTIOUS DISEASES (2022)
Population genomics provides insights into the evolution and adaptation to humans of the waterborne pathogen Mycobacterium kansasii
Tao Luo et al.
NATURE COMMUNICATIONS (2021)
Prosthetic joint infection due to Mycobacterium xenopi: a review of the literature with a new case report
Paola Rodari et al.
INFECTION (2020)
Genomic Insights Into the Mycobacterium kansasii Complex: An Update
Tomasz Jagielski et al.
FRONTIERS IN MICROBIOLOGY (2020)
Mycobacterium simiae: Harmless colonizer or deadly pathogen?
Jean-Francois Jabbour et al.
PLoS Pathogens (2020)
Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline: Executive Summary
Charles L. Daley et al.
CLINICAL INFECTIOUS DISEASES (2020)
Clinical outcomes in Mycobacterium xenopi versus Mycobacterium avium complex pulmonary disease: A retrospective matched cohort study
Ahmad Zaheen et al.
RESPIRATORY MEDICINE (2020)
Mycobacterium szulgai infection as a cause of carpal tunnel syndrome in a patient who kept a Mississippi mud turtle
Jessica Harvey et al.
JOURNAL OF HAND SURGERY-EUROPEAN VOLUME (2019)
Treatment with a macrolide-containing regimen for Mycobacterium kansasii pulmonary disease
Seong Mi Moon et al.
RESPIRATORY MEDICINE (2019)
In Vitro Activity of Bedaquiline and Delamanid against Nontuberculous Mycobacteria, Including Macrolide-Resistant Clinical Isolates
Dae Hun Kim et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Radiologic types of Mycobacterium xenopi pulmonary disease: different patients with similar short-term outcomes
Takashi Hirama et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2019)
Drug Susceptibility Profiling and Genetic Determinants of Drug Resistance in Mycobacterium kansasii
Zofia Bakula et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Clinical, Radiological, and Microbiological Characteristics of Mycobacterium simiae Infection in 97 Patients
Nathalie Coolen-Allou et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Amikacin Inhalation as Salvage Therapy for Refractory Nontuberculous Mycobacterial Lung Disease
Byung Woo Jhun et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
In Vitro Activity of Clofazimine against Nontuberculous Mycobacteria Isolated in Beijing, China
Jingjing Luo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Emergence of Mycobacterium simiae: A retrospective study from a tertiary care center in Lebanon
Amal Hamiehli et al.
PLOS ONE (2018)
Clinical, radiological and molecular features of Mycobacterium kansasii pulmonary disease
Zofia Bakula et al.
RESPIRATORY MEDICINE (2018)
Adjuvant lung resection in the management of nontuberculous mycobacterial lung infection: A retrospective matched cohort study
Maria Luisa Aznar et al.
RESPIRATORY MEDICINE (2018)
Pulmonary isolation and clinical relevance of nontuberculous mycobacteria during nationwide survey in Serbia, 2010-2015
Ivana Dakic et al.
PLOS ONE (2018)
Predictors of developing Mycobacterium kansasii pulmonary disease within 1 year among patients with single isolation in multiple sputum samples: A retrospective, longitudinal, multicentre study
Hung-Ling Huang et al.
SCIENTIFIC REPORTS (2018)
British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)
Charles S. Haworth et al.
THORAX (2017)
A Laboratory-based Analysis of Nontuberculous Mycobacterial Lung Disease in Japan from 2012 to 2013
Kozo Morimoto et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2017)
Microbiological and Clinical Outcomes of Treating Non Mycobacterium Avium Complex Nontuberculous Mycobacterial Pulmonary Disease: A Systematic Review and Meta-Analysis
Roland Diel et al.
CHEST (2017)
Pulmonary Nontuberculous Mycobacteria-Associated Deaths, Ontario, Canada, 2001-2013
Theodore K. Marras et al.
EMERGING INFECTIOUS DISEASES (2017)
Microbiological criteria in non-tuberculous mycobacteria pulmonary disease: a tool for diagnosis and epidemiology
M. Jankovic et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2016)
Epidemiology of Human Pulmonary Infection with Nontuberculous Mycobacteria A Review
D. Rebecca Prevots et al.
CLINICS IN CHEST MEDICINE (2015)
Insights on the Emergence of Mycobacterium tuberculosis from the Analysis of Mycobacterium kansasii
Joyce Wang et al.
GENOME BIOLOGY AND EVOLUTION (2015)
Clinical Significance of Mycobacterium kansasii Isolates from Respiratory Specimens
Seong Mi Moon et al.
PLOS ONE (2015)
Comparison of the Spectrum of Radio logic and Clinical Manifestations of Pulmonary Disease Caused by Mycobacterium avium Complex and Mycobacterium xenopi
Maria C. Carrillo et al.
CANADIAN ASSOCIATION OF RADIOLOGISTS JOURNAL-JOURNAL DE L ASSOCIATION CANADIENNE DES RADIOLOGISTES (2014)
Clinical significance of Mycobacterium szulgai isolates from respiratory specimens
Hongseok Yoo et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2014)
Factors associated with the isolation of Nontuberculous mycobacteria (NTM) from a large municipal water system in Brisbane, Australia
Rachel M. Thomson et al.
BMC MICROBIOLOGY (2013)
Clinical significance of a single isolation of pathogenic nontuberculous mycobacteria from sputum specimens
Won-Jung Koh et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2013)
The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples An NTM-NET collaborative study
Wouter Hoefsloot et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
Improving existing tools for Mycobacterium xenopi treatment: assessment of drug combinations and characterization of mouse models of infection and chemotherapy
Claire Andrejak et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Pulmonary Nontuberculous Mycobacterial Disease, Ontario, Canada, 1998-2010
Theodore K. Marras et al.
EMERGING INFECTIOUS DISEASES (2013)
Drug susceptibility testing and pharmacokinetics question current treatment regimens in Mycobacterium simiae complex disease
Jakko van Ingen et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
Nontuberculous Mycobacterial Lung Disease Prevalence at Four Integrated Health Care Delivery Systems
D. Rebecca Prevots et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Nontuberculous Pulmonary Mycobacteriosis in Denmark Incidence and Prognostic Factors
Claire Andrejak et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
In vitro drug susceptibility of 2275 clinical non-tuberculous Mycobacterium isolates of 49 species in The Netherlands
Jakko van Ingen et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Clinical relevance of Mycobacterium malmoense isolation in the Netherlands
W. Hoefsloot et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Mycobacterium xenopi pulmonary infections: a multicentric retrospective study of 136 cases in north-east France
C. Andrejak et al.
THORAX (2009)
Clinical relevance of non-tuberculous mycobacteria isolated in the Nijmegen-Arnhem region, The Netherlands
J. van Ingen et al.
THORAX (2009)
Outcomes of a standardized triple-drug regimen for the treatment of nontuberculous mycobacterial pulmonary infection
Maeve P. Murray et al.
CLINICAL INFECTIOUS DISEASES (2008)
Clinical relevance of Mycobacterium szulgai in The Netherlands
Jakko van Ingen et al.
CLINICAL INFECTIOUS DISEASES (2008)
Clinical relevance of Mycobacterium simiae in pulmonary samples
J. van Ingen et al.
EUROPEAN RESPIRATORY JOURNAL (2008)
The First Surgical Treatment Case of Pulmonary Mycobacterium malmoense Infection in Japan
Hideaki Ohno et al.
INTERNAL MEDICINE (2008)
Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy
P. A. Jenkins et al.
THORAX (2008)
An official ATS/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases
David E. Griffith et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Pulmonary Mycobacterium kansasii infection in Israel, 1999-2004 -: Clinical features, drug susceptibility, and outcome
D Shitrit et al.
CHEST (2006)
In vitro activity of linezolid, clarithromycin and moxifloxacin against clinical isolates of Mycobacterium kansasii
R Guna et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Nontuberculous mycobacteria in non-HIV patients: epidemiology, treatment and response
MT Henry et al.
EUROPEAN RESPIRATORY JOURNAL (2004)
Mycobacterium simiae outbreak associated with a hospital water supply
NG Conger et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2004)
Aminoglycoside toxicity: Daily versus thrice-weekly dosing for treatment of mycobacterial diseases
CA Peloquin et al.
CLINICAL INFECTIOUS DISEASES (2004)
Mycobacterium szulgai isolated from a patient, a tropical fish and aquarium water
ML Abalain-Colloc et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2003)
Pulmonary disease caused by Mycobacterium xenopi in HIV-negative patients:: five year follow-up of patients receiving standardised treatment
PA Jenkins et al.
RESPIRATORY MEDICINE (2003)
Pulmonary disease caused by M-malmoense in HIV negative patients:: 5-yr follow-up of patients receiving standardised treatment
G Petrie et al.
EUROPEAN RESPIRATORY JOURNAL (2003)
Thrice-weekly clarithromycin-containing regimen for treatment of Mycobacterium kansasii lung disease: Results of a preliminary study
DE Griffith et al.
CLINICAL INFECTIOUS DISEASES (2003)
Mycobacterium simiae pseudo-outbreak resulting from a contaminated hospital water supply in Houston, Texas
HM El Sahly et al.
CLINICAL INFECTIOUS DISEASES (2002)
分享论文
